How to Treat Multiple Myeloma

Links shared publicly online about this topic

Paying for Multiple Myeloma Treatment - Multiple Myeloma Center – EverydayHealth.com

everydayhealth.com — “Multiple myeloma is one of the most expensive cancers to treat. Get advice on how to find financial help and tips for finding the funds you need.View full resource at everydayhealth.com

  • View Related
  • Share

Most Recently Shared on March 26, 2011 at 8:03 pm By:

Oncology Article | Multiple Myeloma

mdlinx.com — “The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapyView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 18, 2011 at 6:56 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or... http://bit.ly/noeEFO #oncology

10 months ago...

Researchers develop new strategy for treating multiple myeloma

news-medical.net — “Multiple myeloma is one of the most common blood cancers, and at present considered to be incurable. In a new study from Uppsala University, researchers now present a conceptually new model for the development and progression of multiple myeloma. The study was done in collaboration with Vrije Universitet Brussels and is published in the July edition of the on-line journal PLoS ONE.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 16, 2010 at 12:17 pm By:

Genetics_News News-Medical.Net Health News

Genetics News: Researchers develop new strategy for treating multiple myeloma: Multiple myeloma is one of the ... http://buzzup.com/13t1b_

2 years ago...

Oncology Article | Multiple Myeloma

mdlinx.com — “Single nucleotide polymorphisms in the promoter region of the IL1B gene influence outcome in multiple myeloma patients treated with high-dose chemotherapy independently of relapse treatment with thalidomide and bortezomibView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 24, 2011 at 5:04 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Single nucleotide polymorphisms in the promoter region of the IL1B gene influence outcome in multiple ... http://bit.ly/f2sW3d #oncology

1 year ago...

Multiple Myeloma | Cancer.Net

cancer.net — “Multiple Myeloma | Cancer.Net - The American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who treat people with cancer. ASCO's members set the standard for patient care worldwide, and lead the fight for more effective cancer treatments, increased funding for clinical and translational research, and, ultimately, cures for the many different cancers that strike millions of people around the world every year.View full resource at cancer.net

  • View Related
  • Share

Most Recently Shared on February 27, 2010 at 7:26 pm By:

teamoncology Naoto T. Ueno Oncologist, Physician, Doctor, and Internist

RT @CancerDotNet Newly updated comprehensive guide to Multiple Myeloma is now available http://ow.ly/1bmfr #cancerinfo

2 years ago...

Study Identifies Key Molecules In Multiple Myeloma

medicalnewstoday.com — “New research links three molecules to a critical tumor suppressor gene that is often turned off in multiple myeloma, a presently incurable cancer of the blood.The findings might offer aView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 28, 2010 at 12:05 pm By:

Scientists combine two agents to treat patients with multiple myeloma

news-medical.net — “Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented data showing that by combining two treatment agents in the care of multiple myeloma patients, doctors can use higher dosages of chemotherapy before autologous stem cell transplant while alleviating painful and debilitating side effects like severe oral mucositis (mouth ulcers).View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 8, 2010 at 10:20 am By:

NewsMedical News-Medical.Net Health News

Scientists combine two agents to treat patients with multiple myeloma: Scientists from the Barbara Ann Karmanos Ca... http://bit.ly/aWAWqt

2 years ago...

A New Era in Treating Patients Who Have Multiple Myeloma

www2.mdanderson.org — “New agents extend patient survival.View full resource at www2.mdanderson.org

  • View Related
  • Share

Most Recently Shared on July 14, 2011 at 6:09 pm By:

First Patient Treated In BioInvent's Phase I Study Of The Drug Candidate BI-505 To Treat Multiple Myeloma

medicalnewstoday.com — “Bioinvent international ab (sto:binv) announced that the first patient has been treated in an open, dose-escalation phase i study of the company's antibody bi-505 for patients with advanced multipView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 5, 2010 at 12:12 pm By:

mnt_cancer MNT Cancer News Health News

First Patient Treated In BioInvent's Phase I Study Of The Drug Candidate BI-505 To Treat Multiple Myeloma http://mnt.to/3vTN

2 years ago...

Thought Leader Perspective: Dr. Kenneth Anderson On Treating Multiple Myeloma - The Myeloma Beacon

myelomabeacon.com — “Dr. Kenneth Anderson is amultiple myelomathought leader, physician and researcher at Dana-Farber Cancer Institute, where he is Director of the ...View full resource at myelomabeacon.com

  • View Related
  • Share

Most Recently Shared on February 23, 2011 at 4:07 pm By:

TheJimmyFund The Jimmy Fund Health Organization

Thought Leader Perspective: Dana-Farber's Dr. Kenneth Anderson On Treating Multiple Myeloma http://ow.ly/41VTG

1 year ago...

Oncology Article | Aspirin Enoxaparin Multiple Myeloma

mdlinx.com — “Aspirin or enoxaparin thromboprophylaxis for newly-diagnosed multiple myeloma patients treated with lenalidomideView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on August 15, 2011 at 5:50 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Aspirin or enoxaparin thromboprophylaxis for newly-diagnosed multiple myeloma patients treated with le... http://t.co/6v4yVN4 #oncology

9 months ago...

New Model of Care for Multiple Myeloma - The People's Pharmacy®

peoplespharmacy.com — “Outpatient Treatment for CancerView full resource at peoplespharmacy.com

  • View Related
  • Share

Most Recently Shared on July 7, 2011 at 6:41 pm By:

PeoplesPharmacy The Peoples Pharmacy Health Site

New Model of Care for Multiple Myeloma - Serious blood cancers like multiple myeloma are frequently treated in the h... http://ow.ly/1dFIlE

11 months ago...

Oncology Medical News about Multiple Myeloma

mdlinx.com — “Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicinView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 2, 2010 at 5:37 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time ... http://bit.ly/aT5MLH #oncology

2 years ago...

DFINE, Inc. Announces Prospective Clinical Trial For Breakthrough Therapy To Treat Spinal Fractures Caused By Multiple Myeloma

medicalnewstoday.com — “DFINE, Inc., the developer of minimally invasive radio frequency (RF) targeted therapies for the treatment of vertebral pathologies, announced today that H. Lee Moffitt Cancer Center and ResearchView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 7, 2011 at 7:05 am By:

mnt_clinical MNT Clinical Trials Health News

DFINE, Inc. Announces Prospective Clinical Trial For Breakthrough Therapy To Treat Spinal Fractures Caused By Multiple... http://mnt.to/3WPS

12 months ago...

Phase III study of REVLIMID for treating patients with multiple myeloma shows improvement in PFS

news-medical.net — “Celgene International Sàrl announced that data from the planned second interim analysis (median follow-up of 21 months) of a phase III, randomized, double-blind study of continuous REVLIMID (lenalidomide) for the treatment of elderly patients with newly diagnosed multiple myeloma show improvement in progression-free survival, the primary endpoint of the study.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 14, 2010 at 1:14 pm By:

Pregnancy_News News-Medical.Net Health News

Pregnancy News: Phase III study of REVLIMID for treating patients with multiple myeloma shows improvement in PFS: ... http://bit.ly/alicKv

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • MedSavingsDoc

    Stephen Meyers, MD

    Links, insights and expert tips to help you save on the costs of your prescriptions and medical care. Also on Facebook (MedSavingsDoc).

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

  • Genetics_News

    News-Medical.Net

    Stay up to date with the latest Genetics news and research via News-Medical.Net

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390